Universal Biosensors Inc (UBI) financial statements (2020 and earlier)

Company profile

Business Address 1 CORPORATE AVENUE
VICTORIA, 3178
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30122620141624
Cash and cash equivalents30122620141624
Restricted cash and investments20     
Receivables05045342
Inventory, net of allowances, customer advances and progress billings1111000
Inventory1111000
Prepaid expense0011111
Other current assets31181099
Total current assets:37643335293036
Noncurrent Assets
Property, plant and equipment561012131416
Intangible assets, net (including goodwill)16     
Intangible assets, net (excluding goodwill)16      
Restricted cash and investments50     
Other noncurrent assets  33333
Total noncurrent assets:2661315161719
TOTAL ASSETS:63704650454855
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2834434
Accounts payable1101101
Accrued liabilities1212222
Employee-related liabilities1122111
Taxes payable 4     
Deferred revenue3
Debt   000 
Business combination, contingent consideration, liability2     
Deferred revenue and credits2  21
Other liabilities333201 
Other undisclosed current liabilities 2     
Total current liabilities:101386565
Noncurrent Liabilities
Long-term debt and lease obligation  1515151414
Long-term debt, excluding current maturities  1515151414
Liabilities, other than long-term debt73610744
Deferred revenue and credits361 1
Deferred revenue1
Asset retirement obligations3333333
Deferred income tax liabilities3
Other liabilities   131 
Other undisclosed noncurrent liabilities0446632
Total noncurrent liabilities:762531272120
Total liabilities:17193337322825
Stockholders' equity
Stockholders' equity attributable to parent, including:45511313132030
Common stock0000000
Additional paid in capital93949393949495
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(43)(80)(80)(81)(74)(65)(53)
Other undisclosed stockholders' equity attributable to parent(5)38(1)1(7)(9)(12)
Total stockholders' equity:45511313132030
TOTAL LIABILITIES AND EQUITY:63704650454855

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7702519171015
Revenue, net2519171015
Cost of revenue
(Cost of Goods and Services Sold)
(4)(3)(4)(1)(1)(1)(12)
Other undisclosed gross profit (0)(0)    
Gross profit:36721181593
Operating expenses(14)(21)(20)(21)(26)(28)(22)
Other undisclosed operating income     60
Operating income (loss):(10)461(4)(10)(14)(18)
Nonoperating income (expense)4(5)(2)5447
Investment income, nonoperating1000000
Foreign currency transaction gain, before tax     11
Other nonoperating income (expense)0 (0)8897
Interest and debt expense (3)(0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes   0000
Income (loss) from continuing operations before equity method investments, income taxes:(6)39(1)1(7)(9)(12)
Other undisclosed income (loss) from continuing operations before income taxes 30(0)   
Income (loss) from continuing operations before income taxes:(6)42(1)1(7)(9)(12)
Income tax expense (benefit)1(4)     
Net income (loss) available to common stockholders, diluted:(5)38(1)1(7)(9)(12)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(5)38(1)1(7)(9)(12)
Other comprehensive income (loss)(0)(0)(0)0   
Comprehensive income (loss), net of tax, attributable to parent:(5)38(1)1(7)(9)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: